Sign in

CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411458152
Phone
206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
Open-market buys, last 90 days
$37,943
in 1 filing
Open-market sales, last 90 days
$1,622,534
in 5 filings

Net −$1,584,591. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lantheus Alpha Therapy, LLC −$1.3M 10% owner sold 3% of stake
  2. Lantheus Holdings, Inc. −$357K 10% owner sold <1% of stake
  3. Spoor Johan M. +$38K Chief Executive Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2024-01-24 Williamson Robert F III Director Purchase +29,862 $0.49 $15K 53,542
2023-12-21 Williamson Robert F III Director Purchase +3,663 $0.33 $1K 3,663
2023-12-19 Williamson Robert F III Director Purchase +13,680 $0.32 $4K 23,680
2023-12-19 Puhlmann Markus Chief Medical Officer Purchase +400,000 $0.34 $137K 1,095,425
2023-12-18 Hunt Jonathan Robert Chief Financial Officer Purchase +125,000 $0.26 $32K 316,710
2023-12-18 Williamson Robert F III Director Purchase +10,000 $0.26 $3K 10,000
2023-12-18 Puhlmann Markus Chief Medical Officer Purchase +60,419 $0.26 $15K 695,425
2023-12-15 Puhlmann Markus Chief Medical Officer Purchase +135,006 $0.27 $36K 635,006
2023-12-15 Woods Lori A Director Purchase +152,962 $0.27 $41K 1,519,738
2023-12-14 Woods Lori A Director Purchase +32,238 $0.27 $9K 1,366,776
2023-12-12 Puhlmann Markus Chief Medical Officer Grant or award · Stock Options (right to buy) +1,477,619 2,885,688
2023-12-12 Spoor Johan M. CEO Grant or award · Stock Options (right to buy) +3,338,878 11,793,635
2023-12-12 Hunt Jonathan Robert Chief Financial Officer Grant or award · Stock Options (right to buy) +1,248,776 2,527,429
2023-12-12 Morich Frank Director Grant or award · Stock Options (right to buy) +230,000 2,037,471
2023-12-12 Williamson Robert F III Director Grant or award · Stock Options (right to buy) +230,000 930,000
2023-12-12 HENSON HEIDI Director Grant or award · Stock Options (right to buy) +230,000 930,000
2023-12-12 Woods Lori A Director Grant or award · Stock Options (right to buy) +230,000 2,412,500
2023-06-12 Streeter Jennifer COO & VP of HR Grant or award · Stock Options (right to buy) +500,000 1,722,500
2023-06-12 Austin Mark John VP Finance/Prin Fin&Acct Offic Grant or award · Stock Options (right to buy) +225,000 773,115
2023-06-02 HENSON HEIDI Director Grant or award · Stock Options (right to buy) +470,000 470,000

Page 5 of 26 · 502 trades